Bis(7)-tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: Comparison with tacrine

Neuroscience Letters

Volumn 290, Issue 3, 2000, Pages 197-200

  Xiao, Xiao Qiu ^a   Lee, Nelson Tze Kin ^a   Carlier, Paul R ^a   Pang, Yuan Ping ^b   Han, Yi Fan ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

Acetylcholinesterase inhibitor; Bis(7) tacrine; Oxidative stress; PC12 cells; Tacrine

Indexed keywords

BIS(7) TACRINE; CATALASE; CHOLINESTERASE INHIBITOR; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MALONALDEHYDE; TACRINE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0034284010     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01357-4     Document Type: Article

References (21)

1. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 57:1999;301-323.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Calderon F.H., von Bemhardi R., De Ferrari G., Luza S., Aldunate R., Inestrosa N.C. Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol. Psychiatry. 3:1998;247-255.
4. Carlier P.R., Han Y.F., Chow E.S.H., Li C.P.L., Wang H., Lieu T.X., Wong H.S., Pang Y.P. Evaluation of short-tether bis(7)-tacrine AChE inhibitors: a further test of the dual bindings site hypothesis. Bioorg. Med. Chem. 7:1999;351-357.
5. Cotman C.W. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging. 19:1998;S29-S32.
6. Davenport C.J., Monyer H., Choi D.W. Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicity. Eur. J. Pharmacol. 154:1988;73-78.
7. Endresen P.C., Prytz P.S., Aarbakke J. A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA. Cytometry. 20:1995;162-171.
8. Giacobini E. Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem. Int. 32:1998;413-419.
9. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210.
10. Jackson L.H., Apffel L., Werrbach-Perez K., Perez-Polo J.R. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J. Neurosci. Res. 25:1990;360-368.
11. Knipper M., de Penha Berzaghi M., Blochl A., Breer H., Thoenen H., Lindholm D. Positive feedback between acetylcholine and neurotrophins nerve growth factor and brain-derived neurotrophic factor in hippocampus. Eur. J. Neurosci. 6:1994;668-671.
12. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
13. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
14. Pang Y.P., Quiram P., Jelacic I., Hong F., Brimijoin S. Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J. Biol. Chem. 271:1996;23646-23649.
15. Robitzki A., Mack A., Hoppe U., Chatonnet A., Layer P.G. Butyrylcholinesterase antisense transfection increases apoptosis in differentiating retinal reaggregates of the chick embryo. J. Neurochem. 71:1998;413-420.
16. Satoh I., Sakai N., Enokido Y., Uchiyama Y., Hatanaka H. Free radical independent protection by nerve growth factor and Bcl-2 of PC12 cells from hydrogen peroxide-triggered apoptosis. J. Biochem. 120:1996;540-546.
17. Soares J.C., Gershon S. THA: historical aspects, review of pharmacological properties and therapeutic effects. Dementia. 6:1995;225-234.
18. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
19. Tang X.C., Han Y.F. Pharmacological profiles of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb. CNS Drug Rev. 5:1999;281-300.
20. Wang H., Carlier P.R., Ho W.L., Lee N.T.K., Li C.P.L., Pang Y.P., Han Y.F. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain Ache. NeuroReport. 10:1999;789-793.
21. Xiao X.Q., Yong J.W., Tang X.C. Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury. Neurosci. Lett. 275:1999;73-76.